Previous close | 37.57 |
Open | 38.03 |
Bid | 38.47 x N/A |
Ask | 35.93 x N/A |
Day's range | 38.03 - 38.03 |
52-week range | 30.28 - 39.72 |
Volume | |
Avg. volume | 84 |
Market cap | 11.398B |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | 21.01 |
EPS (TTM) | 1.81 |
Earnings date | 05 Nov 2024 |
Forward dividend & yield | 1.19 (3.17%) |
Ex-dividend date | 17 May 2024 |
1y target est | N/A |
As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...
FMS continues to gain traction on the back of its broad dialysis product and service portfolio. Ongoing macro challenges raise concerns.
FMS introduces NxStage VersiHD with GuideMe Software to simplify home dialysis and grow its patient base in the United States.